| Bioactivity | PSMA-Val-Cit-PAB-Azide is a drug-linker conjugate for ADC. PSMA-Val-Cit-PAB-Azide contains the cleavable ADCs linker (Val-Cit-PAB) and a novel small-molecule PSMA-targeted conjugate. It contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups[1]. |
| CAS | 2374814-84-1 |
| Formula | C50H65ClN10O13 |
| Molar Mass | 1049.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Aleksei E Machulkin, et al. Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin E Conjugate. J Med Chem. 2021 Dec 9;64(23):17123-17145. |
PSMA-Val-Cit-PAB-Azide
CAS: 2374814-84-1 F: C50H65ClN10O13 W: 1049.56
PSMA-Val-Cit-PAB-Azide is a drug-linker conjugate for ADC. PSMA-Val-Cit-PAB-Azide contains the cleavable ADCs linker (Va
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.